When obese children receive weight-loss treatment, the effects last throughout their lives, and their risk of significant health problems and premature death decreases as they enter young adulthood. However, this is not true for depression and anxiety, according to a Karolinska Institutet study.The study shows that children and adolescents who respond well to obesity treatment…
That would slow the growth of the government’s spending on obesity drugs even as more people on Medicare started using them. New prices for the 10 drugs in the first round of price negotiations were announced last summer. Those prices will go into effect next year. Drugmakers were relieved that those cuts were not deeper….
NEW DELHI: Worried about overeating? Blame the hippocampus — part of the brain responsible for learning and memory — as it may be behind your food craving and the resulting weight gain, according to a study on Wednesday.The study, published in the journal Nature Metabolism, showed that neurons in the hippocampus are encoding memories of…
Obesity should be assessed in a way that goes beyond the standard measure of body mass index, or B.M.I., according to a new definition of the condition released by an international commission. Its report, published Tuesday in The Lancet Diabetes & Endocrinology journal, makes the case for focusing on how much body fat and what…
NEW DELHI: For years, doctors have relied on Body Mass Index (BMI) calculations to assess obesity. However, a global commission convened by The Lancet Diabetes & Endocrinology, a reputed medical journal, now argues that BMI provides inaccurate results.It has suggested doctors should confirm whether a person has obesity or not by at least one other…
“This replicates and reinforces what we already know about sugar-sweetened beverages,” he said, “but the findings highlight their severe costs on health and productivity, especially in Africa and Latin America.” The study detailed intriguing patterns in the consumption of sugary drinks. For example, researchers found that men had modestly higher rates of soda consumption than…
NEW DELHI: Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to launch its blockbuster drug – Tirzepatide – in India in 2025.“India presents a promising market, with a large and growing population, rising disease burden from obesity, diabetes, and cancer, and an increasing health expenditure … A…
BioAge Labs said on Friday it is discontinuing its mid-stage trial studying its experimental drug as a monotherapy and in combination with Eli Lilly’s tirzepatide for the treatment of obesity. The drug developer decided to stop the trial after liver transaminitis, or high levels of certain liver enzymes, were observed in patients receiving the experimental…